Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Observational Study on the Safety of Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma and Lung Cancers in Patients With Pre-Existing Autoimmune Diseases

NCT03140137 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT03140137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03140137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Observational Study on the Safety of Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma and Lung Cancers in Patients With Pre-Existing Autoimmune Diseases
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Completed
Start date
January 21, 2017
Completion date
January 4, 2018
Enrollment
112 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, autoimmune diseases